新鲜囊胚移植前人工皱缩与体外受精结局:一项初步随机对照研究
这项单中心前瞻性随机双盲对照初步研究在2018年5月20日至2022年2月22日纳入150对接受新鲜单囊胚移植的夫妇,比较人工皱缩组与对照组。意向性分析中对照组47对、人工皱缩组95对,符合方案分析中对照组47对、人工皱缩组92对;两组临床妊娠率、多胎妊娠率和活产率均相似,囊胚培养液中游离DNA浓度与体外受精结局无关。作者结论为需大规模随机对照试验确认这些初步结果。
要点
- 新鲜单囊胚移植前对滋养外胚层进行单次激光脉冲人工皱缩,临床妊娠率与对照组相似。
- 意向性分析临床妊娠率对照组48.9% vs 人工皱缩组49.5%(P=0.97),差异无统计学意义。
- 囊胚培养液中游离DNA浓度与体外受精结局无关,作者认为需大规模随机对照试验确认初步结果。
核心结论
- 新鲜囊胚移植前人工皱缩未显示改善临床妊娠率、多胎妊娠率或活产率,作者结论为需大规模随机对照试验确认这些初步结果。
研究设计与样本
- 单中心前瞻性随机双盲对照初步研究,2018年5月20日至2022年2月22日随机纳入150对接受新鲜单囊胚移植的夫妇。
- 人工皱缩组对每个囊胚内细胞团对侧的滋养外胚层细胞连接处施加单次激光脉冲。
- 意向性分析共142对夫妇接受新鲜单囊胚移植:对照组(未行人工皱缩)47对,人工皱缩组95对。
- 排除重大方案偏离后符合方案分析共139对夫妇:对照组47对,人工皱缩组92对。
主要发现
- 两组临床和实验室特征无显著差异。
- 临床妊娠率对照组与人工皱缩组相似:意向性分析48.9% vs 49.5%(P=0.97),符合方案分析48.94% vs 51.1%(P=0.89)。
- 两组多胎妊娠率和活产率也相似。
- 两组 gestational age、出生体重及男/女新生儿比例均无显著差异。
- 囊胚培养液中游离DNA浓度与体外受精结局无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者结论指出需大规模随机对照试验确认这些初步结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does artificial shrinkage before fresh blastocyst transfer improve clinical pregnancy rates in IVF? DESIGN: In this monocentric prospective, randomized, double-blind, controlled pilot study, 150 couples undergoing fresh single-blastocyst transfer were randomized between 20 May 2018 and 22 February 2022. In the artificial shrinkage group (AS group), a single laser pulse was directed to the cellular junction of the trophectoderm on the opposite side of the inner cell mass in each blastocyst. IVF outcomes were clinical pregnancy, multiple pregnancy and live birth rates. Cell-free DNA (cfDNA) concentration was also measured by quantitative real-time PCR in the blastocyst culture medium. RESULTS: In total, 142 couples underwent fresh single-blastocyst transfer: control group, no artificial shrinkage, n = 47; and AS group, artificial shrinkage, n = 95; An intention-to-treat (ITT) analysis was employed. After a reassessment and the exclusion of patients with major protocol deviations, 139 couples underwent fresh single-blastocyst transfer under optimal conditions: control group, n = 47; and AS group, n = 92; a per-protocol analysis was used here. The clinical and laboratory characteristics were not significantly different between the groups. The clinical pregnancy rate was similar in the control and AS groups (ITT: 48.9% versus 49.5%, P = 0.97; per protocol: 48.94% versus 51.1%, P = 0.89). The multiple pregnancy rate and the live birth rate were also similar between the groups. No significant differences in gestational age, birthweight or proportion of male/female newborns were observed. The concentration of cfDNA in the blastocyst culture medium was not associated with IVF outcome. CONCLUSIONS: Large-scale randomized controlled trials are required to confirm these preliminary results.
引用
- Brouillet S, Gala A, Barry F, et al. Artificial shrinkage before fresh blastocyst transfer and IVF outcomes: a pilot randomized controlled study. Reprod Biomed Online. 2024. PMID: 38824764. doi:10.1016/j.rbmo.2024.103941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。